ARCHIVES

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

This article is from The Cancer Letter archive.

Vol. 28 No. 32 | September 6, 2002

Download PDF Visit The Full Archive

Related Articles

Provenge Prolonged Prostate Cancer Survival By Seven Months, Study Finds

September 26, 2003

In Brief: Indiana U. Planning “World Class” Cancer Center; UCLA Names Two New Cancer Control Directors

June 6, 1986

ASCO Recommends Aromatase Inhibitors As Adjuvant For Some Breast Cancer

July 30, 2010

In Brief: Adamson Takes Job at Soft Drink Association; Zack Hall to Direct Neurological Institute

August 12, 1994

Ruckdeschel To Direct Nevada Cancer Institute

February 6, 2009

GSK’s Votrient Approved For Advanced Kidney Cancer

October 30, 2009